Cell line · CVCL_0098
SKM-1
Cancer cell line, Homo sapiens. Adult acute myeloid leukemia. 31 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SKM-1. Cell lines, record CVCL_0098. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0098
On this page
Cell line
As Cellosaurus gives it.
- Name
- SKM-1
- Accession
- CVCL_0098
- RRID
- RRID:CVCL_0098
- Synonyms
- SKM1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 76Y
- Category
- Cancer cell line
- Diseases
- Adult acute myeloid leukemia (NCIt C9154); Myelodysplastic syndrome (NCIt C3247); Acute myeloid leukemia (ORDO Orphanet_519)
- Derived from
- Peripheral blood (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | TP53 mutation indicated incorrectly as being at p.Tyr327His (c.981T>C) in PubMed=8136267. |
Source Cellosaurus
Papers31
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Very Long Chain Fatty Acid Synthesis is a Targetable Dependency in RAS Pathway Mutant Leukemia. | Blood Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Transient mRNA-based CD117 CAR T cells effectively target acute myeloid leukemia in vitro for potential use as a preconditioning strategy. | Immunooncol Technol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities. | Mol Ther Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein. | BMC Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Systematic Evaluation of GAPs and GEFs Identifies a Targetable Dependency for Hematopoietic Malignancies. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis. | Cancer Discov | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML. | Clin Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells. | Elife | 2022 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 31
See all 31 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Derived from it | SKM-1/HHT | CVCL_IM24 |
Source Cell lines
Cell banks3
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| DSMZ | ACC-547 | DSMZ | |
| JCRB | JCRB0118 | JCRB | |
| JCRB | NIHS0147 | Discontinued | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0098
GET https://conductscience.org/api/cell-lines/v1/CVCL_0098/papers?page=2